Noninfectious Uveitis
📧 Sign up to get email alerts when something new happens for Noninfectious Uveitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis [NA]
The trial evaluating immunosuppressants with adalimumab biosimilars versus corticosteroids for noninfectious uveitis is active but not recru…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive Therapy
An ongoing study sponsored by Centre Hospitalier Universitaire Amiens investigates risk factors for therapeutic failure in chronic non-infec…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU [Phase 2]
Phase 2 proof-of-concept study evaluating ESK-001 for active noninfectious uveitis (intermediate, posterior, or panuveitis) was terminated.
-
FDA approval · 2023-07-19FDA Approved: ADALIMUMAB-ADBM — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA approved a supplemental application for ADALIMUMAB-ADBM, a biosimilar of adalimumab from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2023-03-31FDA Approved: YUSIMRY — Supplemental Application (Coherus BioSciences Inc)
FDA approved a supplemental Biologics License Application for YUSIMRY (adalimumab-aqvh) by Coherus BioSciences, authorizing the biosimilar p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis [Phase 2]
A Phase 2 trial evaluating filgotinib for active noninfectious uveitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis [Phase 1, Phase 2]
Clinical trial updates safety and efficacy of suprachoroidal triamcinolone acetonide delivered via microneedle for noninfectious uveitis, co…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Safety and Efficacy of AIN457 in Noninfectious Uveitis [Phase 2]
Phase 2 trial assessing the safety and efficacy of AIN457 (secukinumab) for noninfectious uveitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study [Phase 1, Phase 2]
An early-phase trial evaluating the safety, tolerability, and bioactivity of tocilizumab in adults with noninfectious uveitis (STOP-UVEITIS)…
-
FDA approval · 2014-09-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) to add Cordavis Limited as a supplier. This action supports continued av…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of voclosporin for active noninfectious uveitis. The study sponsored by Lux Bioscienc…
-
FDA approval · 2008-08-05FDA Approved: RETISERT — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for RETISERT (fluocinolone acetonide) from Bausch & Lomb Incorporated.